Veradigm (MDRX) Investor presentation summary

Company overview and market position

• Operates as a healthcare data and technology provider connecting providers, payers, and life sciences, serving a $60B addressable market.

• Expected 2025 revenue is $584–589M, with 2,300 associates and 148M patient records managed.

• Holds a leading position with small- to medium-size independent physician practices.

• Health Network Architecture unifies clinical, financial, and operational data across all segments.

Strategic transformation and growth initiatives

• Implementing a "Reset, Recover, Reignite" strategy to accelerate growth and profitability from 2026.

• Transitioning from flat revenue and poor customer retention to funded growth bets and improved NPS.

• Rationalizing product portfolio, unifying operations, and embedding OKRs at all levels.

• Maintaining $120M in cash and $75M in debt at 2025 year-end to support growth.

Segment-specific solutions and offerings

• Provider segment offers EHR, practice management, revenue cycle, coding, patient engagement, and e-prescribing solutions.

• Payer segment delivers analytics, risk adjustment, care gap closure, and quality reporting services.

• Life sciences segment provides real-world data, clinical evidence, commercial analytics, and regulatory solutions.